You are here

fibrosis

Mediar gets a spark from Pfizer’s Ignite scheme as lead fibrosis programs progress

Fierce Biotech

Wed, 10/25/23 - 10:49 pm

Mediar Therapeutics

Novartis and Pfizer-Backed Mediar Nets $85M for Fibrosis Paradigm Shift

BioSpace

Wed, 03/15/23 - 11:17 am

Mediar Therapeutics

Frazier Launches Lassen to Advance Antibodies Against Fibrosis, Cancer

Xconomy

Wed, 06/17/20 - 09:57 pm

Lassen Therapeutics

Galapagos bags option on 4 more Fibrocor programs

Fierce Pharma

Wed, 01/15/20 - 10:54 am

AbbVie and Scripps Research Enter Research Partnership in Cancer, Immunology, Neurology and Fibrosis

BioSpace

Mon, 12/9/19 - 11:18 pm

Scripps Research Institute

Forbius completes enrollment into phase 1a solid tumour trial of AVID200

Pharmaceutical Business Review

Tue, 10/15/19 - 11:01 am

clinical trials

Evotec, Galapagos enter into collaboration in fibrosis field

Pharmaceutical Business Review

Mon, 02/11/19 - 10:22 am

Galapagos continues fibrosis pipeline buildout with Evotec deal

Fierce Biotech

Thu, 02/7/19 - 09:28 am

AbbVie Commits $100M to Morphic in Fibrosis Drug R&D Alliance

Xconomy

Thu, 10/18/18 - 11:24 am

Morphic Therapeutics

Bristol-Myers, Nitto Ink NASH, Fibrosis Deal

Investopedia

Mon, 11/14/16 - 09:53 am

Bristol-Myers Squibb

Bristol-Myers pens $100M NASH, fibrosis drug deal with Japan’s Nitto

Fierce Biotech

Fri, 11/11/16 - 09:52 am

Bristol-Myers Squibb

Biogen Idec scores lung disease drug in $562.5M buyout of Stromedix

Fierce Biotech

Tue, 02/14/12 - 11:18 am

Amira Pharmaceuticals to Present Preclinical Data on AM152 , an LPA1 Receptor Antagonist, at the Annual Meeting of the American Thoracic Society

PR-USA.net

Sat, 05/14/11 - 01:48 pm

Sanofi May Pay Regulus Up to $750 Million in Deal

Bloomberg

Tue, 06/22/10 - 09:00 am

drug development

Isis Pharmaceuticals